Si è verificato un errore durante il caricamento della pagina.
Il nostro team è stato avvisato ma contattaci tramite il Widget assistenza email se il problema persiste.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 1,6x - 1,7x | 1,6x |
| Selected Fwd Revenue Multiple | 1,4x - 1,6x | 1,5x |
| Fair Value | ₩2.325 - ₩2.530 | ₩2.427 |
| Upside | 44,4% - 57,1% | 50,8% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| WOOJUNG BIO, Inc. | A215380 | KOSDAQ:A215380 |
| C&R Research Inc. | A359090 | KOSDAQ:A359090 |
| The Technology Co.,Ltd. | A043090 | KOSDAQ:A043090 |
| Celemics, Inc. | A331920 | KOSDAQ:A331920 |
| Biotoxtech Co., Ltd. | A086040 | KOSDAQ:A086040 |
| Green Lifescience Co., Ltd. | A114450 | KOSDAQ:A114450 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| A215380 | A359090 | A043090 | A331920 | A086040 | A114450 | |||
| KOSDAQ:A215380 | KOSDAQ:A359090 | KOSDAQ:A043090 | KOSDAQ:A331920 | KOSDAQ:A086040 | KOSDAQ:A114450 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 6.0% | 17.0% | NM- | NM- | 9.8% | -8.0% | ||
| 3Y CAGR | 11.4% | 11.4% | 45.1% | NM- | 8.1% | -0.6% | ||
| Latest Twelve Months | 11.9% | 8.3% | 22.4% | 2.1% | 26.7% | 11.1% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | -8.7% | 10.1% | -96.3% | -61.1% | -4.3% | -10.9% | ||
| Prior Fiscal Year | -10.4% | 11.3% | -111.0% | -87.7% | -26.6% | -20.8% | ||
| Latest Fiscal Year | 4.1% | 6.1% | -128.4% | -28.3% | -20.8% | 1.5% | ||
| Latest Twelve Months | 4.1% | 6.1% | -86.7% | -28.3% | -20.8% | 1.5% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 1.60x | 0.79x | 0.06x | 2.16x | 1.44x | 0.99x | ||
| EV / LTM EBIT | 38.8x | 13.0x | -0.1x | -7.6x | -6.9x | 65.5x | ||
| Price / LTM Sales | 0.59x | 1.00x | 0.34x | 3.58x | 1.08x | 1.30x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 0.06x | 1.44x | 2.16x | |||||
| Historical EV / LTM Revenue | 0.99x | 2.05x | 6.43x | |||||
| Selected EV / LTM Revenue | 1.56x | 1.65x | 1.73x | |||||
| (x) LTM Revenue | 24,861 | 24,861 | 24,861 | |||||
| (=) Implied Enterprise Value | 38,888 | 40,935 | 42,981 | |||||
| (-) Non-shareholder Claims * | 7,513 | 7,513 | 7,513 | |||||
| (=) Equity Value | 46,401 | 48,448 | 50,495 | |||||
| (/) Shares Outstanding | 20.0 | 20.0 | 20.0 | |||||
| Implied Value Range | 2,320.06 | 2,422.39 | 2,524.73 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 2,320.06 | 2,422.39 | 2,524.73 | 1,610.00 | ||||
| Upside / (Downside) | 44.1% | 50.5% | 56.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A215380 | A359090 | A043090 | A331920 | A086040 | A114450 | |
| Enterprise Value | 69,319 | 47,184 | 836 | (646) | 59,514 | 24,687 | |
| (+) Cash & Short Term Investments | 4,448 | 13,121 | 4,519 | 10,066 | 32,384 | 12,885 | |
| (+) Investments & Other | 2,597 | 4,835 | 5,048 | 15,141 | 10,320 | 0 | |
| (-) Debt | (50,985) | (5,447) | (5,787) | (518) | (63,049) | (5,372) | |
| (-) Other Liabilities | 0 | (189) | 104 | (0) | 5,557 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 25,379 | 59,505 | 4,719 | 24,043 | 44,726 | 32,200 | |
| (/) Shares Outstanding | 16.8 | 56.7 | 12.4 | 8.2 | 15.7 | 20.0 | |
| Implied Stock Price | 1,508.00 | 1,049.00 | 380.00 | 2,945.00 | 2,845.00 | 1,610.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,508.00 | 1,049.00 | 380.00 | 2,945.00 | 2,845.00 | 1,610.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |